Standard Contracts
ASSET PURCHASE AGREEMENT BY AND BETWEEN BAYER HEALTHCARE PHARMACEUTICALS INC. AND ARGENX BV November 20, 2020Asset Purchase Agreement • November 23rd, 2020 • Argenx Se • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 23rd, 2020 Company Industry JurisdictionThis ASSET PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of November 20, 2020 (the “Effective Date”), by and between ARGENX BV, a limited liability company organized under the laws of Belgium and having its registered address at Industriepark Zwijnaarde 7, 9052 Zwijnaarde, Belgium (“Buyer”), and BAYER HEALTHCARE PHARMACEUTICALS INC., a company incorporated under the laws of Delaware and having its registered address at 100 Bayer Blvd, Whippany, NJ 07981 (“Seller”). Buyer and Seller may hereinafter be referred to individually as a “Party” and collectively as the “Parties”.